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Question: My patient carries a diagnosis of chronic anemia and has been treated for iron-
deficiency in the past with minimal to no improvement. How can I differentiate between iron-
deficiency anemia and α-thalassemia?  
 
Answer: Although both iron-deficiency anemia (IDA) and thalassemia can present with a 
microcytic hypochromic anemia on a complete blood count (CBC), a few tricks may push you 
towards more strongly considering thalassemia. These include: 
1. Microcytic anemia with a low total red blood cell (RBC) count suggests IDA, while a 
normal to high total RBC count suggests thalassemia.  
2. Microcytic anemia with normal RBC distribution width (RDW) suggests thalassemia 
trait. 
3. In children, where an mean corpuscular volume (MCV) < 80 fL is more common, the 
Mentzer index can be useful: 
a. Mentzer index calculation = (MCV/RBC count); ratio > 13 suggests IDA, < 13 
suggests thalassemia 
b. Note: if patient has both IDA and thalassemia, Mentzer index likely > 13 
 
Iron studies should be ordered to rule out IDA. In thalassemia, they often show normal serum 
iron and serum ferritin levels. This is relevant, as iron supplementation plays no role in the 
treatment of thalassemia and can result in iron overload and secondary hemochromatosis. 
Alternatively, low iron does not rule out thalassemia and should be treated accordingly. 
If still considering a hemoglobinopathy or thalassemia, the next step would be to order a 
peripheral blood smear with review by a pathologist. Target cell presence, in conjunction 
with the CBC findings, will suggest further workup requiring an order for hemoglobin 
electrophoresis. Although hemoglobin electrophoresis cannot diagnose α-thalassemia silent 
carriers (1 gene affected) or trait (2 genes), it is required to exclude other hemoglobinopathies, β-
thalassemias, and, in infants, HbH (3 gene α-thalassemia) or Hb Bart’s (4 gene α-thalassemia). 
If the hemoglobin electrophoresis results indicate normal findings, the work up for α-thalassemia 
is not complete and requires genetic testing. This typically requires an order for an α-
thalassemia panel to identify the most common mutations associated with α-thalassemia. 
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